应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02637 海西新药
开市前 02-11 09:29:14
141.600
+0.000
0.00%
最高
141.600
最低
141.600
成交量
0.00
今开
141.600
昨收
141.600
日振幅
0.00%
总市值
111.45亿
流通市值
111.45亿
总股本
7,871万
成交额
0.00
换手率
0.00%
流通股本
7,871万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
福建海西(2637)宣布认购基金挂钩票据与China Rock Fund 涉资最多4亿港元
公告速递 · 02-05
福建海西(2637)宣布认购基金挂钩票据与China Rock Fund 涉资最多4亿港元
海西新药(02637)认购金融产品
智通财经网 · 02-05
海西新药(02637)认购金融产品
福建海西新药创制(02637)1月无新增发行或股份变动
公告速递 · 02-05
福建海西新药创制(02637)1月无新增发行或股份变动
海西新药02月03日主力净流出14.6万元 散户资金买入
市场透视 · 02-03
海西新药02月03日主力净流出14.6万元 散户资金买入
海西新药01月28日主力净流入31.1万元 散户资金抛售
市场透视 · 01-28
海西新药01月28日主力净流入31.1万元 散户资金抛售
海西新药01月26日主力净流出32.7万元 散户资金买入
市场透视 · 01-26
海西新药01月26日主力净流出32.7万元 散户资金买入
海西新药01月23日获主力加仓15.9万元
市场透视 · 01-23
海西新药01月23日获主力加仓15.9万元
海西新药HX9428片启动Ⅰ期临床 适应症为湿性年龄相关性黄斑变性
新浪财经 · 01-21
海西新药HX9428片启动Ⅰ期临床 适应症为湿性年龄相关性黄斑变性
海西新药01月19日主力净流出28.3万元 散户资金买入
市场透视 · 01-19
海西新药01月19日主力净流出28.3万元 散户资金买入
智通港股52周新高、新低统计|1月16日
智通财经网 · 01-16
智通港股52周新高、新低统计|1月16日
海西新药01月16日获主力加仓77.6万元
市场透视 · 01-16
海西新药01月16日获主力加仓77.6万元
智通港股52周新高、新低统计|1月14日
智通财经 · 01-14
智通港股52周新高、新低统计|1月14日
智通港股52周新高、新低统计|1月12日
智通财经 · 01-12
智通港股52周新高、新低统计|1月12日
海西新药01月09日主力净流出53.9万元 散户资金买入
市场透视 · 01-09
海西新药01月09日主力净流出53.9万元 散户资金买入
福建海西新药创制(02637)12月股份变动月报:股本维持不变
公告速递 · 01-07
福建海西新药创制(02637)12月股份变动月报:股本维持不变
海西新药01月07日主力净流入18.2万元 散户资金抛售
市场透视 · 01-07
海西新药01月07日主力净流入18.2万元 散户资金抛售
海西新药12月29日主力净流出15.3万元 散户资金买入
市场透视 · 2025-12-29
海西新药12月29日主力净流出15.3万元 散户资金买入
海西新药12月23日获主力加仓17.8万元
市场透视 · 2025-12-23
海西新药12月23日获主力加仓17.8万元
冲刺港股通终检窗口:海西新药(02637)的“市值安全垫”与盘面语言
智通财经 · 2025-12-10
冲刺港股通终检窗口:海西新药(02637)的“市值安全垫”与盘面语言
海西新药12月10日获主力加仓164.8万元
市场透视 · 2025-12-10
海西新药12月10日获主力加仓164.8万元
加载更多
公司概况
公司名称:
海西新药
所属市场:
SEHK
上市日期:
--
主营业务:
福建海西新药创制股份有限公司成立于2012年3月27日。公司是一家处于商业化阶段的制药公司,集研发、生产及销售能力于一体,具备在研创新药的管线。公司在中国最大、增长最快的治疗领域拥有多元化的产品组合及管线。截至最后实际可行日期,公司已商业化的产品组合主要包括用于消化系统疾病、心血管系统疾病、内分泌系统疾病、神经系统疾病及炎症疾病的仿制药。根据灼识咨询的资料,该等治疗领域占2023年中国医药销售总额的25%以上。公司的创新药管线专注于具有各种适应症的在研药物,包括一款潜在属同类首款的在研肿瘤药物、一款潜在用于治疗湿性年龄相关性黄斑变性(wAMD)╱糖尿病性黄斑水肿(DME)╱视网膜静脉阻塞(RVO)的首款口服药物及另外两款处于临床前阶段,用于治疗肿瘤及呼吸系统疾病的创新在研药物。公司所有在研创新药均由内部以专有方式开发及发展。
发行价格:
--
{"stockData":{"symbol":"02637","market":"HK","secType":"STK","nameCN":"海西新药","latestPrice":141.6,"timestamp":1770771611214,"preClose":141.6,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":78707270,"shares":78707270,"eps":2.024774,"marketStatus":"开市前","change":0,"latestTime":"02-11 09:29:14","open":141.6,"high":141.6,"low":141.6,"amount":0,"amplitude":0,"askPrice":144,"askSize":50,"bidPrice":141,"bidSize":50,"shortable":0,"etf":0,"ttmEps":2.264,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770773400000},"marketStatusCode":1,"adr":0,"listingDate":1760889600000,"exchange":"SEHK","adjPreClose":141.6,"openAndCloseTimeList":[[1770773400000,1770782400000],[1770786000000,1770796800000]],"volumeRatio":0,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02637","defaultTab":"news","newsList":[{"id":"1124936191","title":"福建海西(2637)宣布认购基金挂钩票据与China Rock Fund 涉资最多4亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1124936191","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124936191?lang=zh_cn&edition=full","pubTime":"2026-02-05 16:41","pubTimestamp":1770280913,"startTime":"0","endTime":"0","summary":"香港主板上市公司福建海西新药创制股份有限公司董事会公告,于2025年10月24日动用闲置资金分别认购由Essence Global Investment Limited发行的基金挂钩票据,认购本金2亿港元,以及最多2亿港元的China Rock Fund SPC。该两项认购构成须予披露交易,最高适用百分比率超过5%但低于25%,需遵守香港上市规则第14章中的通知及公告规定。China Rock Fund SPC为保本产品,预期年化回报率2.5%至6.0%,投资范围包括短期优质货币市场工具与现金等价物,允许随时赎回。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637"],"gpt_icon":0},{"id":"2609223283","title":"海西新药(02637)认购金融产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2609223283","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609223283?lang=zh_cn&edition=full","pubTime":"2026-02-05 16:37","pubTimestamp":1770280650,"startTime":"0","endTime":"0","summary":"智通财经APP讯,海西新药 发布公告,于2025年10月24日,福建海西新药创制股份有限公司(本公司)作为投资者,动用其闲置资金,认购2亿港元由Essence Global Investment Limited根据其10亿美元有担保结构性票据计划发行的2025-32系列基金挂钩票据;及最多2亿港元的China Rock Fund SPC。合理有效地利用临时闲置资金可提高本公司的资本收益,与本公司确保资金安全和流动性以及满足本集团日常运营及股息派付的资金需求这一核心目标一致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402049.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["159940","02637","BK1191"],"gpt_icon":0},{"id":"1124721723","title":"福建海西新药创制(02637)1月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1124721723","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124721723?lang=zh_cn&edition=full","pubTime":"2026-02-05 16:37","pubTimestamp":1770280629,"startTime":"0","endTime":"0","summary":"福建海西新药创制股份有限公司(股份代号:02637)于2026年2月5日公布2026年1月股份变动月报,报告期为2026年1月1日至1月31日。\n截至本月末,公司法定股本为人民币78,707,270元,普通股H股已发行股份总数维持在78,707,270股,无库存股份。报告期内未进行任何新增发行、购回或注销股份,股本结构保持稳定。\n公司同时确认已符合香港联交所对公众持股量的相关要求。公告由公司联席公司秘书张俊环签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637"],"gpt_icon":0},{"id":"2608873387","title":"海西新药02月03日主力净流出14.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2608873387","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608873387?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:15","pubTimestamp":1770106528,"startTime":"0","endTime":"0","summary":"02月03日, 海西新药股价跌2.53%,报收131.00元,成交金额729.8万元,换手率0.07%,振幅5.43%,量比1.10。海西新药今日主力资金净流出14.6万元,上一交易日主力净流入14.7万元。该股近5个交易日下跌8.01%,主力资金累计净流入27.0万元;近20日主力资金累计净流入406.0万元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203161704a476aced&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203161704a476aced&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02637","BK1191"],"gpt_icon":0},{"id":"2607752307","title":"海西新药01月28日主力净流入31.1万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2607752307","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607752307?lang=zh_cn&edition=full","pubTime":"2026-01-28 16:15","pubTimestamp":1769588143,"startTime":"0","endTime":"0","summary":"01月28日, 海西新药股价涨0.28%,报收142.80元,成交金额806.7万元,换手率0.07%,振幅2.32%,量比0.82。海西新药今日主力资金净流入31.1万元,上一交易日主力净流出12.2万元。该股近5个交易日上涨1.56%,主力资金累计净流入122.9万元;近20日主力资金累计净流入424.6万元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128162133a45f730d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128162133a45f730d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02637","BK1191"],"gpt_icon":0},{"id":"2606203893","title":"海西新药01月26日主力净流出32.7万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2606203893","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606203893?lang=zh_cn&edition=full","pubTime":"2026-01-26 16:15","pubTimestamp":1769415317,"startTime":"0","endTime":"0","summary":"01月26日, 海西新药股价跌1.79%,报收142.80元,成交金额591.4万元,换手率0.05%,振幅4.20%,量比0.57。海西新药今日主力资金净流出32.7万元,上一交易日主力净流入15.9万元。该股近5个交易日下跌8.23%,主力资金累计净流入181.9万元;近20日主力资金累计净流入408.3万元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126161648a456ad01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126161648a456ad01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02637"],"gpt_icon":0},{"id":"2605508238","title":"海西新药01月23日获主力加仓15.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605508238","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605508238?lang=zh_cn&edition=full","pubTime":"2026-01-23 16:16","pubTimestamp":1769156166,"startTime":"0","endTime":"0","summary":"01月23日, 海西新药股价涨0.41%,报收145.40元,成交金额780.5万元,换手率0.07%,振幅4.77%,量比0.65。海西新药今日主力资金净流入15.9万元,连续3日净流入,上一交易日主力净流入120.7万元。该股近5个交易日下跌9.97%,主力资金累计净流入186.3万元;近20日主力资金累计净流入459.6万元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123162617a44d9034&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123162617a44d9034&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02637"],"gpt_icon":0},{"id":"2605451467","title":"海西新药HX9428片启动Ⅰ期临床 适应症为湿性年龄相关性黄斑变性","url":"https://stock-news.laohu8.com/highlight/detail?id=2605451467","media":"新浪财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605451467?lang=zh_cn&edition=full","pubTime":"2026-01-21 18:03","pubTimestamp":1768989780,"startTime":"0","endTime":"0","summary":"药物临床试验登记与信息公示平台数据显示,福建海西新药创制股份有限公司的HX9428片在健康试验参与者中单中心、随机、开放、两周期、两序列、双交叉、单次空腹/餐后给药食物影响研究已启动。本次试验主要目的为确定在健康试验参与者中食物摄入对HX9428片药代动力学特性的影响;次要目的为观察HX9428片在健康试验参与者中PK特征和安全性。HX9428片为化学药物,适应症为湿性年龄相关性黄斑变性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121190702a44562d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121190702a44562d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02637"],"gpt_icon":0},{"id":"2604392121","title":"海西新药01月19日主力净流出28.3万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2604392121","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604392121?lang=zh_cn&edition=full","pubTime":"2026-01-19 16:16","pubTimestamp":1768810567,"startTime":"0","endTime":"0","summary":"01月19日, 海西新药股价跌3.65%,报收155.60元,成交金额1019.7万元,换手率0.08%,振幅8.73%,量比0.71。海西新药今日主力资金净流出28.3万元,上一交易日主力净流入77.6万元。该股近5个交易日上涨5.37%,主力资金累计净流入144.7万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入231.9万元,其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119162635a43c13d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119162635a43c13d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02637","BK1191"],"gpt_icon":0},{"id":"2603668519","title":"智通港股52周新高、新低统计|1月16日","url":"https://stock-news.laohu8.com/highlight/detail?id=2603668519","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603668519?lang=zh_cn&edition=full","pubTime":"2026-01-16 16:40","pubTimestamp":1768552801,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,截止1月16日收盘,有123只股票创52周新高,其中天任集团、伟工控股、建成控股创高率位于前3位,分别为103.39%、43.17%、35.59%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1393834.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02635","02655","00842","00001","00386","00162","00368","01429","00262","02285","01233","02276","02259","00340","01113","00083","01133","08418","00180","02637","02685","02661","00002","00086","02350","02516","00016","00014","00876","01205","02381","00659","03858","01196","00440","02631","00695","09696","02521","02650","00590","01201","00826","00065","00017","00005","00631","00358"],"gpt_icon":1},{"id":"2604091681","title":"海西新药01月16日获主力加仓77.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604091681","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604091681?lang=zh_cn&edition=full","pubTime":"2026-01-16 16:15","pubTimestamp":1768551353,"startTime":"0","endTime":"0","summary":"01月16日, 海西新药股价涨3.59%,报收161.50元,成交金额1725.4万元,换手率0.14%,振幅3.85%,量比1.32。海西新药今日主力资金净流入77.6万元,上一交易日主力净流入19.2万元。该股近5个交易日上涨9.72%,主力资金累计净流入146.5万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入307.4万元,其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116162236a7221bbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116162236a7221bbd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02637"],"gpt_icon":0},{"id":"2603695783","title":"智通港股52周新高、新低统计|1月14日","url":"https://stock-news.laohu8.com/highlight/detail?id=2603695783","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603695783?lang=zh_cn&edition=full","pubTime":"2026-01-14 16:40","pubTimestamp":1768380001,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,截止1月14日收盘,有113只股票创52周新高,其中飞道旅游科技、怡园酒业、信达国际控股创高率位于前3位,分别为38.64%、38.57%、25.76%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392742.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01300","00075","02009","00400","00002","01757","00089","00826","01091","01977","03145","00373","02259","00111","00842","00994","01208","00086","09956","01540","09638","00659","00970","01104","00876","00339","02685","00026","08627","01669","08418","03858","06618","02515","00129","01481","00358","00001","01580","02482","01380","02637","02661","08146","01138","00661","00631","02635"],"gpt_icon":1},{"id":"2602597559","title":"智通港股52周新高、新低统计|1月12日","url":"https://stock-news.laohu8.com/highlight/detail?id=2602597559","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602597559?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:40","pubTimestamp":1768207201,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,截止1月12日收盘,有114只股票创52周新高,其中LFG投资控股、TBKS HLDGS、智谱创高率位于前3位,分别为111.24%、63.93%、56.36%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391606.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["08627","01020","01113","00086","00631","01045","00128","08418","09956","01133","00083","00181","00677","02637","07618","00661","00780","01468","01104","00451","06980","00842","00695","03858","01156","01539","00639","00764","01209","02521","00014","00205","01038","00052","01662","02516","01157","02513","00001","02996","09638","00659","01354","00088","00006","01122","00016"],"gpt_icon":1},{"id":"2602424589","title":"海西新药01月09日主力净流出53.9万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2602424589","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602424589?lang=zh_cn&edition=full","pubTime":"2026-01-09 16:15","pubTimestamp":1767946532,"startTime":"0","endTime":"0","summary":"01月09日, 海西新药股价跌0.81%,报收147.10元,成交金额831.0万元,换手率0.07%,振幅3.51%,量比0.66。海西新药今日主力资金净流出53.9万元,上一交易日主力净流入126.8万元。该股近5个交易日上涨11.75%,主力资金累计净流入91.1万元;近20日主力资金累计净流入356.3万元,其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109161806a4af6c9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109161806a4af6c9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02637","BK1191"],"gpt_icon":0},{"id":"1139720557","title":"福建海西新药创制(02637)12月股份变动月报:股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1139720557","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139720557?lang=zh_cn&edition=full","pubTime":"2026-01-07 16:41","pubTimestamp":1767775319,"startTime":"0","endTime":"0","summary":"福建海西新药创制股份有限公司于2026年1月7日提交了截至2025年12月31日的月度股份变动报告。报告显示,公司本月并未进行任何新增发行、购回及注销或库藏股活动,股本结构保持稳定。公司报告期内的法定/注册股本维持人民币78,707,270元,普通股(H股)已发行股数与上月一致,分别为78,707,270股。截至2025年12月31日,公司总股本为78,707,270股,无增减变化。本次公告由公司联席公司秘书张俊环签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637"],"gpt_icon":0},{"id":"2601874108","title":"海西新药01月07日主力净流入18.2万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2601874108","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601874108?lang=zh_cn&edition=full","pubTime":"2026-01-07 16:15","pubTimestamp":1767773720,"startTime":"0","endTime":"0","summary":"01月07日, 海西新药股价涨3.81%,报收141.60元,成交金额1127.9万元,换手率0.10%,振幅3.96%,量比1.35。海西新药今日主力资金净流入18.2万元,上一交易日主力净流出0万元。该股近5个交易日上涨4.20%,主力资金累计净流入32.7万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入306.3万元,其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107161632a4a6cf8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107161632a4a6cf8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02637"],"gpt_icon":0},{"id":"2595737476","title":"海西新药12月29日主力净流出15.3万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2595737476","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595737476?lang=zh_cn&edition=full","pubTime":"2025-12-29 16:15","pubTimestamp":1766996144,"startTime":"0","endTime":"0","summary":"12月29日, 海西新药股价跌0.14%,报收138.80元,成交金额734.9万元,换手率0.07%,振幅4.17%,量比0.61。海西新药今日主力资金净流出15.3万元,上一交易日主力净流入17.8万元。该股近5个交易日上涨2.04%,主力资金累计净流入8.1万元;近20日主力资金累计净流入283.8万元,其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229161931a4853815&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229161931a4853815&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02637","BK1191"],"gpt_icon":0},{"id":"2593187024","title":"海西新药12月23日获主力加仓17.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593187024","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593187024?lang=zh_cn&edition=full","pubTime":"2025-12-23 16:15","pubTimestamp":1766477730,"startTime":"0","endTime":"0","summary":"12月23日, 海西新药股价涨1.22%,报收132.80元,成交金额724.3万元,换手率0.07%,振幅2.52%,量比0.83。海西新药今日主力资金(超大单+大单)净流入17.8万元,上一交易日主力净流入18.6万元。|12月23日主力加仓幅度排名||#|股票简称|主力净额占比|#|高地股份|10.37%|#|南华期货股份|4.01%|#|信能低碳|2.40%|#|...|...|#400|海西新药|0.00%|(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223161722a6c509be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223161722a6c509be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02637"],"gpt_icon":0},{"id":"2590582526","title":"冲刺港股通终检窗口:海西新药(02637)的“市值安全垫”与盘面语言","url":"https://stock-news.laohu8.com/highlight/detail?id=2590582526","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590582526?lang=zh_cn&edition=full","pubTime":"2025-12-10 20:39","pubTimestamp":1765370344,"startTime":"0","endTime":"0","summary":"港股通冲刺策略:基于“全流通”预期的市值管理路径海西新药作为H股上市公司,已提交股份“全流通”申请。海西新药所采取的市值管理策略具有明确的算术逻辑:通过在考察期初期将市值显著提升至门槛之上,构筑所谓的“市值安全垫”。当前,其日均流通市值稳居97.7亿港元之上,为在12月31日的检视窗口前锁定港股通候选资格,构筑了坚实的技术与心理双重“安全垫”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380077.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02637","BK1191"],"gpt_icon":0},{"id":"2590560558","title":"海西新药12月10日获主力加仓164.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590560558","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590560558?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:15","pubTimestamp":1765354511,"startTime":"0","endTime":"0","summary":"12月10日, 海西新药股价涨3.47%,报收134.10元,成交金额1726.7万元,换手率0.16%,振幅6.10%,量比2.12。海西新药今日主力资金净流入164.8万元,上一交易日主力净流入30.6万元。该股近5个交易日上涨0.90%,主力资金累计净流入218.4万元,其中2个交易日为股价下跌时净流入;近20日主力资金累计净流入125.8万元,其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210161534a43f925f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210161534a43f925f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02637","BK1191"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hxpharma.com","stockEarnings":[{"period":"1week","weight":0.0809},{"period":"1month","weight":-0.0374},{"period":"3month","weight":-0.018},{"period":"6month","weight":0.6389},{"period":"ytd","weight":0.0412}],"compareEarnings":[{"period":"1week","weight":0.013},{"period":"1month","weight":0.0363},{"period":"3month","weight":0.0097},{"period":"6month","weight":0.0652},{"period":"1year","weight":0.263},{"period":"ytd","weight":0.0606}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"福建海西新药创制股份有限公司成立于2012年3月27日。公司是一家处于商业化阶段的制药公司,集研发、生产及销售能力于一体,具备在研创新药的管线。公司在中国最大、增长最快的治疗领域拥有多元化的产品组合及管线。截至最后实际可行日期,公司已商业化的产品组合主要包括用于消化系统疾病、心血管系统疾病、内分泌系统疾病、神经系统疾病及炎症疾病的仿制药。根据灼识咨询的资料,该等治疗领域占2023年中国医药销售总额的25%以上。公司的创新药管线专注于具有各种适应症的在研药物,包括一款潜在属同类首款的在研肿瘤药物、一款潜在用于治疗湿性年龄相关性黄斑变性(wAMD)╱糖尿病性黄斑水肿(DME)╱视网膜静脉阻塞(RVO)的首款口服药物及另外两款处于临床前阶段,用于治疗肿瘤及呼吸系统疾病的创新在研药物。公司所有在研创新药均由内部以专有方式开发及发展。","exchange":"SEHK","name":"海西新药","nameEN":"HAIXI PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海西新药(02637)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海西新药(02637)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海西新药,02637,海西新药股票,海西新药股票老虎,海西新药股票老虎国际,海西新药行情,海西新药股票行情,海西新药股价,海西新药股市,海西新药股票价格,海西新药股票交易,海西新药股票购买,海西新药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海西新药(02637)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海西新药(02637)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}